- Research By Topic
- Student Programs
- Executive Programs
- GSB Social Innovators
- Community Engagement
- About CSI
Skip to Content
Change lives. Change organizations. Change the world.
A look at how community advisory committees are faring in the health field.
Toxic environments knock impoverished kids’ systems out of kilter.
Wal-Mart’s innovative approach to environmental sustainability and its addition of health care services to stores were partly triggered by critics of the company in other areas. CEO Lee Scott spoke with Sloan Fellows.
The Population Media Center mixes science with soap operas to protect public health. —By Corey Binns
Being an innovator is never easy. But tackling the needs of underserved patients and healthcare providers in developing countries can be especially difficult. The idiosyncrasies of the healthcare sector, the contextual barriers found in resource-constrained environments, and the already-difficult-to-implement innovation process, make entrepreneurship in global health time consuming, expensive, and risky.
Professor Lawrence Wein, Jeffrey S. Skoll Professor of Management Science, explains why childhood obesity screening may not be that useful.
A professor of organizational behavior argues that "human sustainability" may pay off too.
The success of an innovative new therapy suggests new avenues for incorporating emotional health resources into educational systems worldwide.
Liberals and conservatives have bought into the myth.
A maverick reorganization by an American Heart Association affiliate paves the way for fundraising success.
Nonprofit providers are more cost-effective.
Social media is helping people self-assemble for social action.
A look at how community advisory committees are faring in the health field.
How do you turn a poisonous crisis into a social enterprise? In this university podcast, Lehigh University professor Arup SenGupta talks about his innovative work to remove arsenic from drinking water in South and Southeast Asia, and beyond. SenGupta won the Intel Environment Award at the 2012 Tech Awards.
Entrepreneurs who have gone from concept to commercialization share their experiences with breakthroughs in medical science and technology that have transformed healthcare delivery across the care continuum -- providing patients with less invasive procedures, reduced recovery times, and lower costs. Paul Yock, Professor of Medicine and Founding Co-Chair of Stanford's Program in Biodesign, leads this interactive discussion on medical device innovation at the 2011 Stanford Graduate School of Business Healthcare Summit.
The United States has been a global leader to medical technology innovation, however a changing investment environment and tougher regulatory requirements prove unique challenges for early stage innovators. From the 2011 Stanford Graduate School of Business Healthcare Summit, Stefanos Zenios, director of Stanford's GSB Program in Healthcare Innovation convenes a panel of health care investors who give those entrepreneurs starting out a full picture of the product development cycle and how to successfully raise capital.
The Veteran's Administration, Medicare, and Medicaid make up the largest repository of public health data in the world, and now it's being made available in appropriate forms for the use of patients and innovators alike. Todd Parks, CTO of the U.S. Department of Health and Human Services, wants to change the fee structure of healthcare from "Fee for Service" to something more efficient, and he's freeing up information on public health so everyone can see and help design better health systems.
Liberty and Justice, a for-profit, socially minded company, is creating jobs and improving health care for Liberian women
What if visiting the doctor to get a CT scan was as fun as sailing on a pirate ship? asked Doug Dietz, veteran designer of MRI and CT scan machines. Dietz had seen the widespread anxiety of children who came into the hospital and wanted to change that negative experience.
Investors provide insight on early-stage startup fundraising and advice to those interested in starting their own ventures in healthcare.
How did the global tobacco epidemic start? And what can we learn from it?
In Africa, GlaxoSmithKline had to determine how to address the AIDS crisis while maintaining business viability. The case details the interventions of Stanford business alumnus Jean-Pierre Garnier to set the public tone for the company and its worldwide operations.
These notes discuss the AIDS epidemic including history, treatment, drug pricing, and economics.
A massive South African mining conglomerate was debating how to confront the ravages of HIV/AIDS on the workforce. It considered challenges associated with launching an antiretroviral program.
In an unprecedented move in 1998, Blue Cross of California filed a citizen petition to switch three drugs to over-the-counter status. When the FDA approved, the pharmaceutical companies faced the challenge of developing a strategy for dealing with the threat.
Phyto-Riker, a pharmaceutical company in Ghana, contemplates the effects of the HIV epidemic in Africa on its business plans. It is not certain what resources will be available, and how they will be distributed.
The Center for Science in the Public Interest, started in 1971, was a nonprofit consumer group that focused on nutrition and health. The case describes the center’s media and marketing strategy, which led it to develop a reputation for eye-opening reports about restaurant food.
It’s August 2000, and Maitri AIDS Hospice is reevaluating its approach to fundraising. The associate director for individual gifts is struggling with defining his purpose, and that of individual donors, with an organization for which individual donations still account for only 8 percent of operating expenses.
Diagnostics for the Real World (DRW) focuses on manufacturing and commercializing technologies that addresses the unmet diagnostic needs of patients in developing countries. DRW's first product was a reliable, low-cost Chlamydia Rapid Test (CRT) that made it possible to conduct field-based screenings in remote, low-resource settings. DRW believed the CRTs were commercially attractive; however market introduction was met with stakeholder resistance and funder/consumer misalignment. This case explores the potential gap between the solution and market demand, as well as DRW's response.
Diagnostics of the Real World (DRW), a for-profit spinout from the Diagnostics Development Unit at the University of Cambridge, is focused on manufacturing and commercializing technologies created at the university that can help address the unmet diagnostic needs of patients in developing countries. DRW's first product was a reliable, low-cost Chlamydia Rapid Test (CRT) that made it feasible to conduct field- based chlamydia screenings. The team discovered that although chlamydia was a significant global health concern, its as not necessarily a top priority for nongovernmental organizations. There was also no ready-make market or large-scale demand for the CRT in developing countries. The case study describes the multi-source funding strategy DRW devised to support its operations without losing sight of its mission.
Traditional Borders (BTB), Rice 360°’s undergraduate program, challenges students to solve global health problems through real-world engineering design. By pairing students with faculty, clinicians, and mentors in developing world, BTB teams had designed an impressive portfolio for effective, low-cost medical technologies. However, the temporary nature of student teams and specialized focus of these inventions proved difficult to realize these projects in the market to create consistent solutions. This mini-case study tells the story of of BTB began working with 3rd Stone Design, a design, strategy, and development consultancy, to accelerate progress on their project DosRight Syringe Clip out of the lab and into the market.
When 3rd Stone Design, a product design, strategy, and development consultancy, licensed the DoseRight Syringe Clip out of the Rice University Beyond Traditional Borders (BTB) program, the Clinton Health Access Initiative (CHAI) had placed a preliminary order for 200,000 units. The DoseRight product was a simple plastic clip, inserted into the top portion of a standard oral syringe to facilitate the accurate pediatric dosing of liquid ARV medications in countries with widespread HIV/AIDs. However, 3rd Stone Design encountered problems when their prototype could not be manufactured in high volumes at an affordable price. This case study explores how 3rd Stone Design modified its product design to fulfill the CHAI order.
When a team at Stanford University accepted a challenge to design a low-cost prosthetic knee joint that could be produced locally for use in the JaipurFoot Organization's clinics across India, the students were eager to dive into the technical aspects of developing a product. However, they learned the organization already used an inexpensive joint that through research, discovered that associated emotional and psychological issues needed to be addressed in creating a better design.
Seasonal influenza leads to >200,000 hospitalizations and >8,000 deaths in the United States each year. The influenza vaccine is widely available at low cost and reduces mortality, morbidity, and healthcare costs. Nevertheless, many of those for whom vaccination is indicated fail to comply with CDC recommendations for vaccination. If low compliance is the result of careful calculations by individuals weighing the costs and beneﬁts of vaccination, it may be difﬁcult and expensive for policymakers and organizational leaders to increase vaccination rates. However, if low compliance is the result of forgetfulness or procrastination, low-cost interventions that use psychological tools may be effective at increasing vaccination rates and improving public health.
Evidence suggests that the medication lists of patients are often incomplete and could negatively affect patient outcomes. By predicting drugs the patient could be taking, collaborative ﬁltering can be a valuable tool for reconciling medication lists.
Workers who earn just below the Social Security tax threshold receive a larger tax preference for health insurance than workers who earn just above it.
Health care providers may vertically integrate not only to facilitate coordination of care, but also for strategic reasons that may not be in patients’ best interests.
Young companies trying to enter parts of the health care industry by focusing on helping patients stay healthy and allowing safety net providers to use their resources have a hard time attracting venture capital funds that focus more on traditional profit. A recent article by two Stanford Graduate School of Business researchers argues that it's time to change this pattern.
The two-quarter Elective Course series provides lectures from a diverse group of faculty that expose students to the practical aspects of technology invention and development. The class features a presentation or discussion from one of the guest speakers or faculty. Students work in small project teams in the Biodesign prototyping lab or bench space, collaborating with the fellows of the program.
The purpose of this class is to provide students with the economic tools and the institutional and legal background to understand how markets for health care products and services work. The class utilizes case studies, lectures, and visits from individuals in the industry.
This course examines health care businesses and how they use technology (primarily biotechnology, medical technology, and information technology) to improve patient outcomes and manage costs. Through case studies, students gain an in-depth understanding of how new technologies get developed and commercialized in health care, and of how the whole health care value chain adapts to new technologies.
This course examines the application of cost-effectiveness and cost-benefit analysis, along with other evaluation techniques, to products and services such as medical care, whose "output" is difficult to measure. It critically reviews studies that apply cost analysis techniques to specific clinical problems.
Vision care is something that is practically taken for granted in the United States, but that’s not the case throughout much of the world. Some 300 million around the globe suffer from correctable vision loss, leading, as Ashanthi Mathai, MBA '04, says, “to people accepting their vision impairment and adjusting their lives around it.” The result? A lower quality of life, restricted job options, and even further economic distress.
Jane Chen's passion for helping others has taken her on an incredible journey from doing social work in China to founding Embrace, a company that sells premature infant incubators.
Caring for aging parents is a challenge many face, yet there is no clear path or pattern for how to manage this stage of life. Karen Routt shares her expertise at the nexus between technology and caring for the elderly.
With a high-tech background, an MBA, and an M.D., Dr. Patty Einarson has a unique perspective on the intersection of technology, business and medicine. She leverages this knowledge by contributing to math/science education in the public schools, encouraging the kids of today to become future innovators.
Mark Cafferty is passionate about empowering individuals to be all they can be. He channels funds to employment and youth service programs.
A conversation on health care innovation with former Senate majority leader and surgeon Bill Frist.
Abbott’s John Capek discusses health care device regulation, transparency, and the critical relationship between physicians and their patients
The head of the Permanante Federation says innovation is critical to improving U.S. health care.
In an interview with Kewen Jin, the serial entrepreneurs discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
While at Stanford, the Embrace team developed an idea for an infant warmer to help low-birth-weight-infants. As designed, the warmer was small and light, transportable, and easy to use, and had the potential to be produced at a fraction of the cost of available incubators. The team decided to pursue their idea by creating a nonprofit called Embrace Global to further develop and commercialize the technology. Through discussion with its board of directors and other advisors, the team thought transitioning from a prototype to a market-ready product would require funding and considered equity investments. However, the team realized in using private investors, it could be more difficult to justify targeting market segments who are considered small commercially. This mini-case study explores how Embrace decided to pursue a hybrid structure and steps to balance competing priorities in a new model.